Vivos Therapeutics, Inc.VVOSNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank67
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-1.93
↑ 64% vs avg
Percentile
P67
Within normal range
Streak
2 yr
Consecutive declineElevated
Average
-5.32
Historical baseline
PeriodValueYoY Change
2024-1.93-73.2%
2023-1.12-187.9%
2022-0.39+83.5%
2021-2.35+73.6%
2020-8.93+14.0%
2019-10.37+14.6%
2018-12.15-